Search Results

InspireMD Announces PIs for C-GUARDIANS II Trial Evaluating the SwitchGuard Neuroprotection System

February 12, 2024—InspireMD, Inc. named Patrick Geraghty, MD, and Patrick Muck, MD, as the lead Principal Investigators (PIs) for the company’s upcoming C-GUARDIANS II clinical trial for the SwitchGuard neuroprotection system (NPS).  According to the company, the C-GUARDIANS II study will aim to advance clearance of SwitchGuard NPS and associated tools, which are designed to allow the treating physician to reverse cerebral blood flow during a transcarotid artery revascularization procedure, preventing embolic debris generated during the procedure from traveling to the brain by passing the blood through the filter enclosed within the SwitchGuard before returning it to the patient to minimize blood loss.

LIVE Procedure Performed in the Netherlands With BioVentrix Revivent TC System

November 21, 2016—BioVentrix, Inc. announced the first clinical use in the Netherlands of its Revivent TC transcatheter ventricular enhancement system.

Survey of Heart Valve Patients Shows Need for Increased Awareness About Clinical Trial Enrollment

November 5, 2020—Most heart valve patients are not very aware of clinical trials, but most patients would consider enrolling in a clinical trial, according to results of a nationwide survey announced by HeartValveSurgery.com, an advocacy group for patients with heart valve disease.